Heart Transplantation
📧 Sign up to get email alerts when something new happens for Heart Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2012-01-16Clinical Trial Update: Comparison of Coronary CT With IVUS in Heart Transplant Population [NA]
A clinical trial comparing Coronary CT with IVUS in heart transplant recipients was withdrawn.
-
CLINICAL_TRIALS trial_result · 2011-11-02Clinical Trial Update: Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Comparison to Mycophenolate Mofetil (MMF) in de Nove Heart Patients [Phase 4]
A Phase 4 study compares enteric-coated mycophenolate sodium with mycophenolate mofetil in de novo heart transplant patients, evaluating eff…
-
CLINICAL_TRIALS research · 2011-08-26Clinical Trial Update: Pharmacology of Immunosuppressants Following Heart Transplantation
A clinical trial update focusing on the pharmacology of immunosuppressants after heart transplantation; no current status or results are pro…
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients [Phase 4]
Phase 4 study assessing safety and efficacy of converting from a calcineurin inhibitor to sirolimus in renally impaired heart transplant rec…
-
CLINICAL_TRIALS trial_result · 2011-04-18Clinical Trial Update: Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation [Phase 4]
Phase 4 clinical trial update for everolimus (Certican) in heart and lung transplantation; study completed with results posted in 2011.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-02-21Clinical Trial Update: Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens [Phase 3]
A Phase 3 trial comparing tacrolimus- and cyclosporine-based immunoprophylaxis regimens in heart transplant recipients has completed with re…
-
FDA approval · 2010-09-17FDA Approved: TACROLIMUS — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved the original application for tacrolimus from Mylan Pharmaceuticals, enabling generic access to this immunosuppressant used to p…
-
CLINICAL_TRIALS research · 2010-08-30Clinical Trial Update: Exploration of Fatigue, Uncertainty, Depression and Quality of Life in Heart Transplantation Recipients
This clinical trial update describes a completed study examining fatigue, uncertainty, depression, and quality of life in people who have un…
-
FDA approval · 2010-06-10FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (Strides Pharma Science Limited)
FDA approved a generic version of mycophenolate mofetil under an Original Application by Strides Pharma Science Limited. Indications include…
-
CLINICAL_TRIALS trial_result · 2010-01-12Clinical Trial Update: Shift to Everolimus (RAD) Kidney Sparing Study [Phase 4]
A Phase 4 kidney-sparing study evaluating Everolimus (RAD) for patients with kidney dysfunction in the context of heart transplantation has …
-
FDA approval · 2009-11-30FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Accord Healthcare's generic mycophenolate mofetil. The product is used to prevent organ transpla…
-
CLINICAL_TRIALS withdrawal · 2009-11-17Clinical Trial Update: Non-invasive Evaluation of Heart Transplant Rejection- Pilot Study
This pilot study evaluating non-invasive methods to assess heart transplant rejection was withdrawn prior to completion.
-
FDA approval · 2009-10-08FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved Genentech's supplemental application for Cellcept (mycophenolate mofetil hydrochloride).
-
CLINICAL_TRIALS research · 2009-10-07Clinical Trial Update: Medication Adherence Enhancement in Heart Transplant Recipients [NA]
This clinical trial update describes a Hannover Medical School study aimed at improving medication adherence and self-management in heart tr…
-
FDA approval · 2009-05-04FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved an original application for a generic mycophenolate mofetil manufactured by Mylan Pharmaceuticals Inc, for organ transplant rej…
-
CLINICAL_TRIALS trial_result · 2009-02-16Clinical Trial Update: Exchange of Azathioprine by Mycophenolatmofetile and Cyclosporine A Dose Reduction After Heart Transplantation [NA]
This clinical trial evaluates exchanging azathioprine for mycophenolate mofetil and reducing cyclosporine A dose after heart transplantation…
-
FDA approval · 2009-02-13FDA Approved: PROGRAF — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for PROGRAF (tacrolimus) from Astellas Pharma US, Inc., indicating an approved change to the existin…
-
CLINICAL_TRIALS trial_result · 2009-02-13Clinical Trial Update: Withdrawal of Steroids, Cyclosporine A Dose Reduction and Switch to Mycophenolatmofetile After Heart Transplantation [NA]
The trial update notes withdrawal of steroids, reduction of cyclosporine A dose, and switch to mycophenolate mofetil after heart transplanta…
-
FDA approval · 2007-12-20FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for CellCept to update labeling, expanding its use for prevention of organ transplant rejection in r…
-
FDA approval · 2007-10-17FDA Approved: SIROLIMUS — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Sirolimus from Mylan Pharmaceuticals Inc., indicating an approved change or addition to the prod…
-
FDA approval · 2007-09-21FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for CellCept (mycophenolate mofetil) from Genentech, Inc., likely resulting in an updated indica…
-
CLINICAL_TRIALS trial_result · 2007-08-28Clinical Trial Update: Effects of Chocolate on Coronary Vasomotion in Patients After Heart Transplantation [Phase 1]
A Phase 1 clinical trial investigates whether chocolate consumption affects coronary vasomotion in heart transplant recipients. The study ha…
-
CLINICAL_TRIALS trial_result · 2007-06-15Clinical Trial Update: Intracellular and Renal/Myocardial Tissue Concentrations of Cyclosporine A (CsA) and Rejection Frequency Following Transplantation [Phase 4]
Phase 4 clinical trial update examining intracellular and renal/myocardial tissue concentrations of cyclosporine A and rejection frequency i…
-
FDA approval · 2007-05-02FDA Approved: SIROLIMUS — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for sirolimus submitted by Mylan Pharmaceuticals Inc., resulting in changes to the labeling and/…
-
CLINICAL_TRIALS trial_result · 2007-03-19Clinical Trial Update: Nitrate and Hypertension in Heart Transplanted Patients [Phase 4]
Phase 4 clinical trial update examining nitrate therapy and blood pressure control in heart transplant patients.